In ovarian cancers, Hudson et al. describe overexpressed lipids, chemokines, metalloproteinases, growth factors, and other receptor ligands in the peritoneal fluid that stimulate both these receptors and downstream RAC1, leading to the metastatic phenotype [40]. This evidence concerns the gene RAC1 and ovarian carcinoma.